ArticleEuropean journal of drug metabolism and pharmacokinetics2022

Assessment of the Effects of Inhibition or Induction of CYP2C19 and CYP2C9 Enzymes, or Inhibition of OAT3, on the Pharmacokinetics of Abrocitinib and Its Metabolites in Healthy Individuals.

Xiaoxing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.